Helsinn announces FDA acceptance of IND application

NEXT STORY
Brandywine Realty Trust to Present at the Stifel 2020 Cross Sector Insight Conference
PREV STORY
Ascendis Pharma A/S Announces Participation in ENDO Online 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma Announces Enrollment of Last Patient in the BEKINDA® Phase II Study for IBS-D

Top-line results are expected in the third quarter of 2017  The randomized, double-blind, placebo-controlled Phase ...

author_avatar
NASDAQ Market News

RedHill Biopharma to Present at BioNetwork East 2016 Partnering Summit

TEL-AVIV, Israel, April 25, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” ...

author_avatar
NASDAQ Market News

Reata Pharmaceuticals, Inc. Presents Interim Phase 1b Data for Omaveloxolone in the Treatment of Unresectable or Metastatic Melanoma

IRVING, Texas, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the ...

author_avatar
NASDAQ Market News